Showing results (1431-1440 of 1,506) with videos related to

Sort By:
Pageof 151
EMBO Reports|February 8, 2024
ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearanceSuzanne Faure-Dupuy, Jamil Jubrail, Manon Depierre, et al.
The Journal of Experimental Medicine|July 22, 2021
Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lungDavide Pisu, Lu Huang, Vipin Narang, et al.
Immunology|November 2, 2006
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccineSteven C Derrick, Teresa H Evering, Vasan K Sambandamurthy, et al.
The British Journal of Radiology|December 21, 2012
The value of image-guided intensity-modulated radiotherapy in challenging clinical settingsS J Treece, M Mukesh, Y L Rimmer, et al.
Stem Cell Research|August 26, 2016
Derivation of the clinical grade human embryonic stem cell line RCe021-A (RC-17)P A De Sousa, B J Tye, K Bruce, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2013
Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assaysMarcelo Jose Andrade Oliveira, Hendrick E van Deventer, Lorin M Bachmann, et al.
Bioconjugate Chemistry|December 10, 2015
Fluorescent Bisphosphonate and Carboxyphosphonate Probes: A Versatile Imaging Toolkit for Applications in Bone Biology and BiomedicineShuting Sun, Katarzyna M Błażewska, Anastasia P Kadina, et al.
Genes and Immunity|November 18, 2016
MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineageN T T Thuong, T T B Tram, T D Dinh, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.
Bone|August 31, 2015
The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutantsMaria K Tsoumpra, Joao R Muniz, Bobby L Barnett, et al.
Pageof 151